GRI Bio, Inc. (GRI)
USD 0.75
(-4.1%)
USD 0.75
(-4.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.14 Million | -1.08 Million | -847 Thousand | -3.7 Million | -2.88 Million | -2.37 Million |
| Net Income | -13.03 Million | -3.21 Million | -1.55 Million | -4.82 Million | -3.46 Million | -4.31 Million |
| Depreciation & Amortization | 57 Thousand | 50 Thousand | 49 Thousand | 75 Thousand | 735.00 | 612.00 |
| Deferred income taxes | 1.65 Million | 325 Thousand | - | - | - | - |
| Stock-based compensation | 388 Thousand | 25 Thousand | - | - | - | - |
| Change in working capital | 1.68 Million | 1.51 Million | 563 Thousand | 887 Thousand | 159.66 Thousand | 461.3 Thousand |
| Other non-cash items | 115 Thousand | 217 Thousand | 100 Thousand | -676 Thousand | 462.1 Thousand | 1.19 Million |
| Investing Cash Flow | -8000.00 | -3000.00 | -3.84 Million | -2000.00 | - | -2204.00 |
| Investments in PPE | -8000.00 | -3000.00 | - | -2000.00 | - | -2204.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -699 Thousand | -640 Thousand | -3.84 Million | - | - | - |
| Sales/Maturities of investments | 357 Thousand | 4.42 Million | - | - | - | - |
| Other Investing Activities | 190 Thousand | -3.78 Million | - | - | - | - |
| Financing Cash Flow | 10.94 Million | 1 Million | 600 Thousand | -4000.00 | 6.09 Million | 2.98 Million |
| Debt repayment | -1.25 Million | -250 Thousand | -244 Thousand | -4000.00 | -1.11 Million | - |
| Dividends payments | -2.91 Million | - | - | - | - | - |
| Common Stock Repurchased | - | -124 Thousand | - | - | - | - |
| Common Stock Issuance | 11.74 Million | 3.44 Million | 100 Thousand | - | 4.98 Million | 2.98 Million |
| Other Financing Activities | -2.04 Million | 1.38 Million | 744 Thousand | - | -4.00 | - |
| Accounts receivables | -417 Thousand | - | - | - | - | - |
| Accounts payables | 2.15 Million | 897 Thousand | 54 Thousand | 980 Thousand | -40.28 Thousand | 286.61 Thousand |
| Inventory | -21 Thousand | - | - | - | - | - |
| Other working capital | -479 Thousand | 618 Thousand | 509 Thousand | -93 Thousand | 199.95 Thousand | 174.69 Thousand |
| Cash at beginning of period | 9000.00 | 90 Thousand | 337 Thousand | 3.82 Million | 612.65 Thousand | - |
| Cash at end of period | 1.8 Million | 9000.00 | 90 Thousand | 109 Thousand | 3.82 Million | 612.65 Thousand |
| Capital Expenditure | -8000.00 | -3000.00 | - | -2000.00 | - | -2204.00 |
| Effect of forex changes on cash | - | - | 3.84 Million | 106.00 | - | - |
| Net cash flow / Change in cash | 1.79 Million | -81 Thousand | -247 Thousand | -3.71 Million | 3.2 Million | 612.65 Thousand |
| Free Cash Flow | -9.14 Million | -1.08 Million | -847 Thousand | -3.7 Million | -2.88 Million | -2.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.25 Million | -1.88 Million | -2 Million | -13.03 Million | -2.13 Million | -6.5 Million |
| Depreciation & Amortization | 1000.00 | 1000.00 | 15 Thousand | 57 Thousand | 1000.00 | 2000.00 |
| Deferred income taxes | - | - | -2.76 Million | 1.65 Million | -45 Thousand | - |
| Stock-based compensation | 37 Thousand | 37 Thousand | 36 Thousand | 388 Thousand | 326 Thousand | -59 Thousand |
| Change in working capital | 213 Thousand | -366 Thousand | -3.4 Million | 1.68 Million | 531 Thousand | 4.42 Million |
| Other non-cash items | -447 Thousand | 795 Thousand | 2.56 Million | 115 Thousand | 13 Thousand | 2.13 Million |
| Investing Cash Flow | - | - | - | -8000.00 | - | -8000.00 |
| Investments in PPE | - | - | - | -8000.00 | - | -8000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -699 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 357 Thousand | - | - |
| Other Investing Activities | - | - | - | 190 Thousand | - | - |
| Financing Cash Flow | 4.4 Million | 4.48 Million | 3.88 Million | 10.94 Million | -11 Million | 6.91 Million |
| Debt repayment | - | - | -11 Million | -1.25 Million | -11 Million | -1.25 Million |
| Dividends payments | - | - | - | -2.91 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.4 Million | 4.48 Million | 11 Million | 11.74 Million | -11 Million | 11.74 Million |
| Other Financing Activities | -557 Thousand | -1.01 Million | 3.88 Million | -2.04 Million | 11 Million | -3.57 Million |
| Accounts receivables | - | - | - | -417 Thousand | - | - |
| Accounts payables | 344 Thousand | -744 Thousand | -2.7 Million | 2.15 Million | 681 Thousand | 4.62 Million |
| Inventory | - | - | - | -21 Thousand | - | - |
| Other working capital | -131 Thousand | 378 Thousand | -706 Thousand | -479 Thousand | -150 Thousand | -203 Thousand |
| Cash at beginning of period | 4.09 Million | 1.8 Million | 3.48 Million | 9000.00 | 4.79 Million | 1.66 Million |
| Cash at end of period | 6.35 Million | 4.09 Million | 1.8 Million | 1.8 Million | 3.48 Million | 4.79 Million |
| Capital Expenditure | - | - | - | -8000.00 | - | -8000.00 |
| Effect of forex changes on cash | - | - | - | - | - | -3.77 Million |
| Net cash flow / Change in cash | 2.26 Million | 2.28 Million | -1.68 Million | 1.79 Million | -1.31 Million | 3.13 Million |
| Free Cash Flow | -2.14 Million | -2.2 Million | -5.56 Million | -9.14 Million | -1.31 Million | -11 Thousand |
ITM
PRMG
STS
VOYA-PB
6707
DECK